These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4812618)

  • 1. Relative influence of obesity and diabetes on plasma alpha-cell glucagon.
    Gossain VV; Matute ML; Kalkhoff RK
    J Clin Endocrinol Metab; 1974 Feb; 38(2):238-43. PubMed ID: 4812618
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma glucagon in obesity. Response to arginine, glucose and protein administration.
    Kalkhoff RK; Gossain VV; Matute ML
    N Engl J Med; 1973 Aug; 289(9):465-7. PubMed ID: 4587235
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin and glucagon response to glucose and arginine in two patients with "autoimmune" diabetes mellitus.
    Del Prete GF; Tiengo A; Bersani G; Nosadini R; Garotti C; Trisotto A
    Horm Metab Res; 1976 Mar; 8(2):149-50. PubMed ID: 1261966
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glucagon and insulin concentrations in acromegaly.
    Trimble ER; Atkinson AB; Buchanan KD; Hadden DR
    J Clin Endocrinol Metab; 1980 Sep; 51(3):626-31. PubMed ID: 6997331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.
    Lefebvre PJ; Luyckx AS; Lecomte MJ
    Horm Metab Res; 1976; Suppl 6():91-8. PubMed ID: 1278843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
    Balázsi I; Varsányi-Nagy M; Nagy K
    Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Glucagon and blood sugar.
    N Engl J Med; 1976 May; 294(22):1238-40. PubMed ID: 177868
    [No Abstract]   [Full Text] [Related]  

  • 11. [Some aspects of the dynamic behavior of IRI in obesity and in diabetes mellitus].
    Squadrito G
    Minerva Med; 1979 May; 70(23):1651-8. PubMed ID: 450305
    [No Abstract]   [Full Text] [Related]  

  • 12. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects.
    Passariello N; Paolisso G; Sgambato S; D'Onofrio F
    Diabete Metab; 1987; 13(4):436-40. PubMed ID: 3315764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon, insulin and growth hormone response in obese women.
    Fallucca F; Menzinger G; Gambardella S; Tamburrano S; Andeani D
    Acta Diabetol Lat; 1975; 12(3-4):239-43. PubMed ID: 1224907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
    Cucinotta D; Quartarone M; Saitta A; Sardo A; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2290-6. PubMed ID: 754729
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I.R.I. after glucagon administration in groups of obese subjects, with no family history of diabetes, with normal glucose tolerance test, with chemical diabetes, or with mild not ketotic diabetes mellitus.
    Adezati L; Prando R; Cristofolini MP; Pagliaini R
    Acta Isot (Padova); 1970; 10(3):319-32. PubMed ID: 5003714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
    Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
    Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose, insulin and glucagon in the diabetic goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.